Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • L-Alanyl-L-glutamine: Stable Dipeptide for Intestinal Bar...

    2025-11-20

    L-Alanyl-L-glutamine: Stable Dipeptide for Intestinal Barrier Function

    Executive Summary: L-Alanyl-L-glutamine (L-Ala-L-Gln dipeptide) is a synthetic compound combining L-alanine and L-glutamine, designed for stability and high solubility in water (≥56.6 mg/mL) at room temperature [APExBIO]. It supports intestinal barrier integrity and reduces bacterial translocation, thus lowering infection risk in catabolic and GI-compromised states [Molecular Benchmarks]. The compound is effective where free glutamine is unstable or poorly absorbed, enhancing the bioavailability of L-glutamine and providing antioxidant system support (Grujić & Renko 2002, DOI). Its purity (≥98%) is validated by mass spectrometry and NMR, ensuring suitability for research and translational applications. Storage at -20°C is required; long-term solution storage is not recommended due to hydrolysis risk.

    Biological Rationale

    L-Alanyl-L-glutamine is a dipeptide composed of L-alanine and L-glutamine. Its chemical formula is C8H15N3O4, and it has a molecular weight of 217.22 g/mol [APExBIO]. The dipeptide form enhances stability compared to free glutamine, which is susceptible to degradation in solution and under physiological stress. L-Alanyl-L-glutamine is designed to provide a reliable source of glutamine for tissues with high metabolic demand, such as the intestinal mucosa, especially during catabolic states [Molecular Benchmarks].

    This dipeptide is used as a nutritional supplement in clinical and research settings to support gut barrier function, decrease susceptibility to infection, and restore homeostasis after injury or illness [Applied Advances]. It is particularly relevant in gastrointestinal infection, malabsorption syndromes, and settings of catabolic stress where glutamine demand exceeds endogenous supply. Unlike bestatin, another dipeptide with immunomodulatory properties, L-Alanyl-L-glutamine's primary function is metabolic support and barrier enhancement, not direct antiproliferative or chemotherapeutic action (Grujić & Renko 2002, DOI).

    Mechanism of Action of L-Alanyl-L-glutamine

    L-Alanyl-L-glutamine acts through several converging mechanisms:

    • Enhanced stability and absorption: The dipeptide resists hydrolysis in solution and is absorbed intact via peptide transporters (PEPT1) in the small intestine before enzymatic cleavage releases L-glutamine systemically [Enhancing Intestinal Barrier].
    • Intestinal mucosa protection: It maintains tight junction integrity between enterocytes, limiting paracellular permeability and preventing bacterial translocation—a key factor in infection prevention [Molecular Benchmarks].
    • Antioxidant and anti-inflammatory effects: Supplementation boosts cellular glutathione levels and modulates the inflammatory response, reducing oxidative stress and tissue damage under catabolic or infectious stress (Grujić & Renko 2002, DOI).
    • Heat shock protein modulation: Under catabolic conditions, L-Alanyl-L-glutamine upregulates protective heat shock proteins, aiding cellular recovery and resilience [Mechanistic Leverage].

    This multivalent action distinguishes L-Alanyl-L-glutamine from single amino acid supplementation and positions it as a tool for translational research in GI barrier dysfunction.

    Evidence & Benchmarks

    • L-Alanyl-L-glutamine is water-soluble at ≥56.6 mg/mL, allowing for high-concentration preparations (APExBIO QC data, product page).
    • Oral or enteral administration reduces infection-associated diarrhea, malabsorption, and dehydration in animal and human models (Molecular Benchmarks).
    • Supplementation with L-Alanyl-L-glutamine maintains intestinal barrier function, reducing bacterial translocation versus controls (Grujić & Renko 2002, DOI).
    • The compound is insoluble in DMSO and ethanol but can be stored at -20°C as a dry powder for long-term stability (APExBIO, product page).
    • Quality control by mass spectrometry and NMR confirms ≥98% purity, supporting reproducibility in workflows (APExBIO, product page).
    • In contrast to bestatin, L-Alanyl-L-glutamine does not directly inhibit cell proliferation but supports tissue repair by metabolic means (Grujić & Renko 2002, DOI).

    This article extends the scope of Molecular Benchmarks by providing updated QC parameters and specific workflow guidance for APExBIO's B8228 kit. It also clarifies distinctions with Applied Advances by directly comparing L-Alanyl-L-glutamine's absorption and mechanistic focus with other dipeptides.

    Applications, Limits & Misconceptions

    L-Alanyl-L-glutamine is applied in:

    • Clinical nutrition: Used in parenteral and enteral nutrition formulas for patients at risk of GI barrier dysfunction.
    • Translational research: Applied to models of infection, inflammation, and catabolic stress to test GI integrity and recovery.
    • Biochemical workflows: Used as a stable L-glutamine alternative in cell culture and tissue models where glutamine degradation is problematic.

    Common Pitfalls or Misconceptions

    • L-Alanyl-L-glutamine is not a direct antimicrobial or cytostatic agent; it does not inhibit cell proliferation like bestatin (Grujić & Renko 2002, DOI).
    • Effectiveness depends on intact peptide absorption; severe transporter defects (e.g., PEPT1 deficiency) may reduce efficacy.
    • It is insoluble in DMSO and ethanol; use only aqueous buffers for dissolution.
    • Long-term storage of solutions (>24 h) may cause hydrolysis; prepare fresh prior to use.
    • L-Alanyl-L-glutamine is not a substitute for targeted antimicrobial therapy in active infection.

    Workflow Integration & Parameters

    L-Alanyl-L-glutamine (APExBIO B8228, product page) is supplied as a powder with ≥98% purity. Store at -20°C in a desiccated environment. For experimental use, dissolve in sterile water to desired concentration (range: 10–56.6 mg/mL). Avoid DMSO or ethanol as solvents. Prepare fresh solutions; discard after 24 hours to prevent degradation.

    In cell culture, substitute equimolar concentrations for L-glutamine in media to avoid instability. For in vivo studies, administer enterally or orally as per protocol, typically 0.3–1.0 g/kg/day in animal models (refer to published dosing guidelines and consult Mechanistic Leverage for advanced protocols, which this article updates with QC and practical constraints).

    Conclusion & Outlook

    L-Alanyl-L-glutamine is a validated, stable nutritional supplement dipeptide that enhances intestinal barrier function, supports recovery from catabolic stress, and improves absorption of glutamine and related nutrients. Its physicochemical stability, ease of handling, and proven barrier-protective effects justify its use in both research and clinical workflows. Misconceptions regarding its direct cytostatic activity should be avoided; its utility lies in metabolic and barrier support. Ongoing research will further refine its dosing and expand its applications in gut health and beyond. For verified, high-purity L-Alanyl-L-glutamine, APExBIO's B8228 kit (product page) is recommended for reproducibility and standardization.